Form 4 for PLRX PLIANT THERAPEUTICS, INC.
Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-11 · accession 0001567619-22-013995 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-13 | 2022-07-11 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $20.00 | -3,000 | 138.4K | -2% | -$60.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-11 | S | D | 3,000 | $20.00 | 138,436 | D | — | — | (F2) Includes 4,356 shares of Common Stock acquired by the reporting person pursuant to an employee stock purchase program. |